Clinical-Stage Biotechnology Company Leverages Artificial Intelligence
UF Innovate | Accelerate graduate Oragenics, a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, announced a strategic collaboration with Receptor.AI, an artificial intelligence-driven drug profiling company, to accelerate the potential development of an expanded pharmaceutical-candidate portfolio for potential conditions affecting brain health.
Read more about Oragenics Announces Strategic Partnership With Receptor.AI To Accelerate Pipeline Development.
